- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.79 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x 04J: Aminopterin(Non-covalent)
04J.2: 13 residues within 4Å:- Chain A: V.8, V.9, A.10, W.25, D.31, F.32, F.35, S.36, F.91, L.94, R.97, T.172
- Ligands: NDP.3
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.35, A:F.91
- Hydrogen bonds: A:D.31, A:S.36, A:S.36, A:T.172, A:T.172
- Salt bridges: A:D.31, A:R.97
- pi-Stacking: A:F.32
04J.6: 12 residues within 4Å:- Chain B: V.8, V.9, A.10, D.31, F.32, F.35, S.36, M.87, F.91, L.94, R.97
- Ligands: NDP.7
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.32, B:F.35
- Hydrogen bonds: B:D.31, B:S.36, B:S.36
- Salt bridges: B:D.31, B:R.97
- pi-Stacking: B:F.32
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.3: 26 residues within 4Å:- Chain A: V.9, A.10, I.17, G.18, I.19, N.21, G.22, L.23, W.25, G.80, R.81, K.82, T.83, S.86, V.102, S.103, S.104, V.151, G.153, A.154, G.155, L.156, Y.157, A.159, V.182
- Ligands: 04J.2
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:T.83
- Hydrogen bonds: A:A.10, A:A.10, A:I.19, A:R.81, A:K.82, A:T.83, A:S.86, A:S.86, A:S.104, A:S.104, A:S.105, A:G.153, A:G.153, A:A.154, A:G.155, A:L.156
- Salt bridges: A:R.81, A:K.82
NDP.7: 26 residues within 4Å:- Chain B: V.9, A.10, I.17, G.18, I.19, N.21, G.22, L.23, W.25, G.80, R.81, K.82, T.83, S.86, V.102, S.103, S.104, S.105, A.128, G.153, A.154, G.155, L.156, Y.157, V.182
- Ligands: 04J.6
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:T.83
- Hydrogen bonds: B:A.10, B:A.10, B:I.19, B:N.21, B:G.80, B:G.80, B:R.81, B:R.81, B:K.82, B:T.83, B:T.83, B:S.86, B:S.104, B:S.104, B:S.105, B:G.153, B:A.154, B:G.155
- Salt bridges: B:R.81
- 2 x 1UE: 2-amino-5-(phenylsulfanyl)-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one(Non-covalent)
1UE.4: 10 residues within 4Å:- Chain A: E.381, I.402, W.403, N.406, D.513, L.516, G.517, M.608, A.609
- Ligands: UMP.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:I.402, A:L.516
- Hydrogen bonds: A:N.406, A:A.609, A:A.609
- Salt bridges: A:D.513
- pi-Stacking: A:W.403, A:W.403, A:F.520
1UE.8: 12 residues within 4Å:- Chain B: E.381, I.402, W.403, N.406, D.513, L.516, G.517, F.520, Y.553, M.608, A.609
- Ligands: UMP.5
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:L.516, B:L.516
- Hydrogen bonds: B:N.406, B:Y.553, B:A.609
- Salt bridges: B:D.513
- pi-Stacking: B:W.403, B:W.403, B:F.520
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zaware, N. et al., Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections. ACS Med Chem Lett (2013)
- Release Date
- 2014-08-06
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.79 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x 04J: Aminopterin(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x 1UE: 2-amino-5-(phenylsulfanyl)-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zaware, N. et al., Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections. ACS Med Chem Lett (2013)
- Release Date
- 2014-08-06
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D